Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jorge E Toblli, Gabriel Cao, Luis Rico & Margarita Angerosa. (2017) Cardiovascular, liver, and renal toxicity associated with an intravenous ferric carboxymaltose similar versus the originator compound. Drug Design, Development and Therapy 11, pages 3401-3412.
Read now
Read now
Jürgen Stein, Ayşegül Aksan, Karima Farrag, Axel Dignass & Heinfried H Radeke. (2017) Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice. Expert Opinion on Pharmacotherapy 18:16, pages 1721-1737.
Read now
Read now
Monika Praschberger, Carolin Cornelius, Markus Schitegg, Hans Goldenberg, Barbara Scheiber-Mojdehkar & Brigitte Sturm. (2015) Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD. Pharmaceutical Development and Technology 20:2, pages 176-182.
Read now
Read now
Yves Beguin & Aurélie Jaspers. (2014) Iron sucrose – characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. Expert Opinion on Pharmacotherapy 15:14, pages 2087-2103.
Read now
Read now
Eun Sil Lee, Bo Ra Park, Jeong Sig Kim, Gyu Yeon Choi, Jeong Jae Lee & Im Soon Lee. (2013) Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients. Current Medical Research and Opinion 29:2, pages 141-147.
Read now
Read now
Articles from other publishers (34)
Zhuo Sun, Ji Jiang & Xia Chen. (2020) Evaluation of Therapeutic Equivalence for the Follow-On Version of Intravenously Administered Non-Biological Complex Drugs. Clinical Pharmacokinetics 59:8, pages 995-1004.
Crossref
Crossref
Iain C. Macdougall, Josep Comin-Colet, Christian Breymann, Donat R. Spahn & Ioannis E. Koutroubakis. (2020) Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency. Advances in Therapy 37:5, pages 1960-2002.
Crossref
Crossref
Benjamin Elstrott, Lubna Khan, Sven Olson, Vikram Raghunathan, Thomas DeLoughery & Joseph J. Shatzel. (2019) The role of iron repletion in adult iron deficiency anemia and other diseases. European Journal of Haematology 104:3, pages 153-161.
Crossref
Crossref
Tiziana Di Francesco, Léadie Delafontaine, Erik Philipp, Elmira Lechat & Gerrit Borchard. (2020) Iron polymaltose complexes: Could we spot physicochemical differences in medicines sharing the same active pharmaceutical ingredient?. European Journal of Pharmaceutical Sciences 143, pages 105180.
Crossref
Crossref
K. Klein, P. Stolk, M.L. De Bruin, H.G.M. Leufkens, D.J.A. Crommelin & J.S.B. De Vlieger. (2019) The EU regulatory landscape of non-biological complex drugs (NBCDs) follow-on products: Observations and recommendations. European Journal of Pharmaceutical Sciences 133, pages 228-235.
Crossref
Crossref
Tiziana Di Francesco, Emmanuelle Sublet & Gerrit Borchard. (2019) Nanomedicines in clinical practice: Are colloidal iron sucrose ready-to-use intravenous solutions interchangeable?. European Journal of Pharmaceutical Sciences 131, pages 69-74.
Crossref
Crossref
Alejandro Martin‐Malo, Gerrit Borchard, Beat Flühmann, Claudio Mori, Donald Silverberg & Ewa A. Jankowska. (2019) Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients. ESC Heart Failure 6:2, pages 241-253.
Crossref
Crossref
M. Aapro, Y. Beguin, C. Bokemeyer, M. Dicato, P. Gascón, J. Glaspy, A. Hofmann, H. Link, T. Littlewood, H. Ludwig, A. Österborg, P. Pronzato, V. Santini, D. Schrijvers, R. Stauder, K. Jordan & J. Herrstedt. (2018) Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Annals of Oncology 29, pages iv96-iv110.
Crossref
Crossref
Sunil Bhandari, Dora Pereira, Helen Chappell & Hal Drakesmith. (2018) Intravenous Irons: From Basic Science to Clinical Practice. Pharmaceuticals 11:3, pages 82.
Crossref
Crossref
Amy Barton Pai, Manjunath P. Pai, Dan E. Meyer, Brian C. Bales, Victoria E. Cotero, Nan Zheng & Wenlei Jiang. (2018) In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations. Regulatory Toxicology and Pharmacology 97, pages 17-23.
Crossref
Crossref
Julia Schnorr, Sören Fütterer, Karsten Spicher, Maria Catarinolo, Christoph Schlösser, Harald Enzmann & Peter Langguth. (2018) Bioequivalence decision for nanoparticular iron complex drugs for parenteral administration based on their disposition. Regulatory Toxicology and Pharmacology 94, pages 293-298.
Crossref
Crossref
Tiziana Di Francesco & Gerrit Borchard. (2018) A robust and easily reproducible protocol for the determination of size and size distribution of iron sucrose using dynamic light scattering. Journal of Pharmaceutical and Biomedical Analysis 152, pages 89-93.
Crossref
Crossref
Jacques Rottembourg & Guy Rostoker. (2018) L’utilisation de génériques en transplantation : vers des solutions rationnelles et sures !. La Presse Médicale 47:3, pages 199-210.
Crossref
Crossref
Dajun Sun, Rodney Rouse, Vikram Patel, Yong Wu, Jiwen Zheng, Alokita Karmakar, Anil Patri, Priyanka Chitranshi, David Keire, Jia Ma & Wenlei Jiang. (2018) Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Physicochemical Characterization. Nanomaterials 8:1, pages 25.
Crossref
Crossref
Tiziana Di Francesco, Erik Philipp & Gerrit Borchard. (2017) Iron sucrose: assessing the similarity between the originator drug and its intended copies. Annals of the New York Academy of Sciences 1407:1, pages 63-74.
Crossref
Crossref
Amy Barton Pai. (2017) Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation. Annals of the New York Academy of Sciences 1407:1, pages 17-25.
Crossref
Crossref
Alain Astier, Amy Barton Pai, Marco Bissig, Daan J.A. Crommelin, Beat Flühmann, Jean-Daniel Hecq, Josefien Knoeff, Hans-Peter Lipp, Alberto Morell-Baladrón & Stefan Mühlebach. (2017) How to select a nanosimilar. Annals of the New York Academy of Sciences 1407:1, pages 50-62.
Crossref
Crossref
Peng Zou, Katherine Tyner, Andre Raw & Sau Lee. (2017) Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products. The AAPS Journal 19:5, pages 1359-1376.
Crossref
Crossref
Nan Zheng, Dajun D. Sun, Peng Zou & Wenlei Jiang. (2017) Scientific and Regulatory Considerations for Generic Complex Drug Products Containing Nanomaterials. The AAPS Journal 19:3, pages 619-631.
Crossref
Crossref
AB Pai, DE Meyer, BC Bales, VE Cotero, MP Pai, N Zheng & W Jiang. (2017) Performance of Redox Active and Chelatable Iron Assays to Determine Labile Iron Release From Intravenous Iron Formulations. Clinical and Translational Science 10:3, pages 194-200.
Crossref
Crossref
Jacques Rottembourg & Guy Rostoker. (2015) Utilisation des dérivés injectables du fer au cours de la maladie rénale chronique : intérêts, limites et conseils pour un bon usage. Néphrologie & Thérapeutique 11:7, pages 531-542.
Crossref
Crossref
Gian Carlo Di Renzo, Filippo Spano, Irene Giardina, Eleonora Brillo, Graziano Clerici & Luis Cabero Roura. (2015) Iron Deficiency Anemia in Pregnancy. Women's Health 11:6, pages 891-900.
Crossref
Crossref
Karsten Spicher, Susanne Brendler-Schwaab, Christoph Schlösser, Maria Catarinolo, Sören Fütterer, Peter Langguth & Harald Enzmann. (2015) Differences in tissue distribution of iron from various clinically used intravenous iron complexes in fetal avian heart and liver.. Regulatory Toxicology and Pharmacology 73:1, pages 65-72.
Crossref
Crossref
Daan J.A. Crommelin, Vinod P. Shah, Imre Klebovich, Scott E. McNeil, Vera Weinstein, Beat Flühmann, Stefan Mühlebach & Jon S.B. de Vlieger. (2015) The similarity question for biologicals and non-biological complex drugs. European Journal of Pharmaceutical Sciences 76, pages 10-17.
Crossref
Crossref
Jorge E. Toblli, Gabriel Cao & Margarita Angerosa. (2015) Nitrosative stress and apoptosis in non-anemic healthy rats induced by intravenous iron sucrose similars versus iron sucrose originator. BioMetals 28:2, pages 279-292.
Crossref
Crossref
Stefan Mühlebach & Beat Flühmann. 2015. Non-Biological Complex Drugs. Non-Biological Complex Drugs
149
170
.
Huub Schellekens, Sven Stegemann, Vera Weinstein, Jon S. B. de Vlieger, Beat Flühmann, Stefan Mühlebach, Rogério Gaspar, Vinod P. Shah & Daan J. A. Crommelin. (2013) How to Regulate Nonbiological Complex Drugs (NBCD) and Their Follow-on Versions: Points to Consider. The AAPS Journal 16:1, pages 15-21.
Crossref
Crossref
S. Fütterer, I. Andrusenko, U. Kolb, W. Hofmeister & P. Langguth. (2013) Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD). Journal of Pharmaceutical and Biomedical Analysis 86, pages 151-160.
Crossref
Crossref
Taija S. Koskenkorva-Frank, Günter Weiss, Willem H. Koppenol & Susanna Burckhardt. (2013) The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: Insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radical Biology and Medicine 65, pages 1174-1194.
Crossref
Crossref
Vinod P. Shah, Arnold G. Vulto & Stefan Mühlebach. (2013) Workshop on the challenges in substitution of nonbiological complex drugs. American Journal of Health-System Pharmacy 70:21, pages 1879-1880.
Crossref
Crossref
Fernando Gomollón & Javier P. Gisbert. (2013) Current Management of Iron Deficiency Anemia in Inflammatory Bowel Diseases: A Practical Guide. Drugs 73:16, pages 1761-1770.
Crossref
Crossref
Xinyuan Zhang, Nan Zheng, Robert A Lionberger & Lawrence X Yu. (2013) Innovative approaches for demonstration of bioequivalence: the US FDA perspective. Therapeutic Delivery 4:6, pages 725-740.
Crossref
Crossref
Fernando Gomollón & Javier P. Gisbert. (2013) Intravenous iron in inflammatory bowel diseases. Current Opinion in Gastroenterology 29:2, pages 201-207.
Crossref
Crossref
Gerrit Borchard, Beat Flühmann & Stefan Mühlebach. (2012) Nanoparticle iron medicinal products – Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies. Regulatory Toxicology and Pharmacology 64:2, pages 324-328.
Crossref
Crossref